Skip to main content

Neuropathy clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Single vs. Multiple Privigen Dose Regimens in Pediatric CIDP

    Sorry, in progress, not accepting new patients

    A randomized, open‑label, prospective, multicenter study designed to investigate 2 dose regimens in pediatric subjects 2 to < 17 years of age with confirmed or possible CIDP, either previously exposed to IVIG treatment or unexposed to IVIG treatment

    San Francisco, California and other locations

Last updated: